Prosecution Insights
Last updated: November 20, 2026

Kyle W. Kretzer, USPTO Patent Examiner

Listed by the USPTO as KRETZER, KYLE W.

Tech Center 3700 • Art Units: 3774 3791 3796

This examiner grants 65% of resolved cases

Analysis

KRETZER, KYLE W. works in Tech Center 3700 and Art Unit 3774. The record covers 187 resolved cases, with an allowance rate of 64.7% and a median of 1281 days to allowance. The interview lift is 40.6%, indicating a favorable association between interviews and allowance outcomes.

The leading companies are The Regents of the University of California, Abbott Laboratories, and Roche Diabetes Care Inc. The listed firms are DINSMORE & SHOHL LLP, ARENTFOX SCHIFF LLP - New York, and Bookoff McAndrews, PLLC. These participants provide a useful starting point for reviewing related prosecution histories.

The case volume supports using the interview measure as a meaningful planning signal. Counsel may benefit from a structured interview strategy, while still tailoring amendments and arguments to the application record.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

64.7%
Allow Rate
-5.3% vs TC avg
246
Total Applications
+40.6%
Interview Lift
1281
Avg Prosecution Days
Based on 187 resolved cases, 2023–2026

Rejection Statute Breakdown

13.4%
§101 Eligibility
14.0%
§102 Novelty
44.3%
§103 Obviousness
25.1%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18810419 CONTROLLING PATIENT MONITORING DEVICES Non-Final OA Cilag GmbH International
18729383 A Machine Learning Pipeline for Highly-Sensitive Assessment of Rotator Cuff Function Final Rejection The Regents of the University of California
19080266 Computing Device Having Miniaturized Impedance Plethysmography Sensor for Measuring Blood Flow Non-Final OA Google LLC
18830480 DEVICES AND METHODS FOR THE MITIGATION OF NON-ANALYTE SIGNAL PERTURBATIONS INCIDENT UPON ANALYTE-SELECTIVE SENSOR Non-Final OA Biolinq Incorporated
17628598 DETECTING APPARATUS AND DETECTING METHOD Final Rejection MAXELL, LTD.
18289608 BIOLOGICAL INFORMATION ACQUISITION DEVICE, BIOLOGICAL INFORMATION ACQUISITION METHOD, AND RECORDING MEDIUM Final Rejection NEC Corporation
19055255 HOME-BASED LABOR ONSET DETECTION SYSTEM AND METHOD Non-Final OA GE Precision Healthcare LLC
19018361 SYSTEM, APPARATUS, AND METHOD FOR EVALUATING VASCULAR ENDOTHELIAL FUNCTION Non-Final OA Murata Manufacturing Co., Ltd.
19074133 TRANSCUTANEOUS SENSOR WITH DUAL ELECTRODES AND METHODS OF DETECTING AND COMPENSATING FOR WITHDRAWAL OF A TRANSCUTANEOUS SENSOR FROM A PATIENT Non-Final OA ABBOTT DIABETES CARE INC.
18705641 SYSTEMS, DEVICES, AND METHODS FOR ANALYTE MONITORING Final Rejection ABBOTT DIABETES CARE INC.
18147755 SYSTEMS AND METHODS FOR ANALYTE MONITORING Non-Final OA ABBOTT DIABETES CARE INC.
17008101 ADJUSTING SETTINGS TO DIFFERENT DEGREES OF AGGRESSIVENESS IN AN AUTOMATED INSULIN DELIVERY SYSTEM BASED ON QUALITY OF BLOOD GLUCOSE LEVEL CONTROL BY A USER Final Rejection Insulet Corporation
18315858 METHOD FOR PRODUCING AN ANALYTE SENSOR, AN ANALYTE SENSOR, AND A USE THEREOF Non-Final OA Roche Diabetes Care, Inc.
18307071 ANALYTE SENSOR SYSTEM AND A METHOD FOR ITS PRODUCING Final Rejection Roche Diabetes Care, Inc.
18535086 GUIDE WIRE Non-Final OA ASAHI INTECC CO., LTD.
18636187 OMNIPHOBIC PAPER BASED SMART BANDAGE DEVICES Non-Final OA Purdue Research Foundation
18856968 Systems, methods and devices for assessing hearing Non-Final OA THE BIONICS INSTITUTE OF AUSTRALIA

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Kyle W. Kretzer's allowance rate?

64.7% of resolved applications examined by Kyle W. Kretzer were allowed (187 resolved cases), compared with 61.7% across Art Unit 3774 over the last five years.

Does an interview help with examiner Kyle W. Kretzer?

This examiner's interview lift is +40.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Kyle W. Kretzer take to allow a patent?

Applications allowed by Kyle W. Kretzer took 1,281 days on average from filing to allowance.

Which art unit does examiner Kyle W. Kretzer work in?

Kyle W. Kretzer examines applications in Art Unit 3774 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month